ABSTRACT Basal-like breast carcinomas, characterized by unfavorable prognosis and frequent metastases, are associated with epithelial-to-mesenchymal transition. During this process, cancer cells undergo cytoskeletal reorganization and up-regulate membrane-type 1 matrix metalloproteinase (MT1-MMP; MMP14), which functions in actin-based pseudopods to drive invasion by extracellular matrix degradation. However, the mechanisms that couple matrix proteolysis to the actin cytoskeleton in cell invasion have remained unclear. On the basis of a yeast two-hybrid screen for the MT1-MMP cytoplasmic tail-binding proteins, we identify here a novel Src-regulated protein interaction between the dynamic cytoskeletal scaffold protein palladin and MT1-MMP. These proteins were coexpressed in invasive human basal-like breast carcinomas and corresponding cell lines, where they were associated in the same matrix contacting and degrading membrane complexes. The silencing and overexpression of the 90-kDa palladin isoform revealed the functional importance of the interaction with MT1-MMP in pericellular matrix degradation and mesenchymal tumor cell invasion, whereas in MT1-MMP-negative cells, palladin overexpression was insufficient for invasion. Moreover, this invasion was inhibited in a dominant-negative manner by an immunoglobulin domaincontaining palladin fragment lacking the dynamic scaffold and Src-binding domains. These results identify a novel protein interaction that links matrix degradation to cytoskeletal dynamics and migration signaling in mesenchymal cell invasion.
INTRODUCTION
Metastasis of tumor cells to distant sites in the human body is the major cause of cancer mortality. One of the important mechanisms promoting metastasis is epithelial-to-mesenchymal transition (EMT), which is a common phenomenon in several types of epithelial cancers, including triple-negative breast cancers (TNBCs; Thiery et al., 2009) . In this process, neoplastic epithelium uses invasive programs, involving dissociation of epithelial cell junctions, loss of apical-basolateral polarization, cytoskeletal reorganization, and protein expression required for mesenchymal invasion (Thiery et al., 2009, Yilmaz and Christofori, 2009 ). Mesenchymal invasion is defined by elongated cell morphology and dynamic membrane protrusions tailored for extracellular matrix (ECM) degradation (Friedl and Wolf, 2009; Poincloux et al., 2009; Murphy and Courtneidge, 2011) .
For the pericellular ECM degradation, many types of tumor and stromal cells use membrane-type matrix metalloproteinases (MT-MMP) to allow invasion and growth across basement membranes and dense interstitial or provisional matrices (Sabeh et al., 2004; Rowe and Weiss, 2009; Kessenbrock et al., 2010) . MT1-MMP The homologous protein palladin is expressed in multiple tissues and up-regulated in certain invasive tumors in a more similar pattern with MT1-MMP (73% similarity within the two most C-terminal Ig domains of palladin and myotilin; BLAST [http://blast.ncbi .nlm.nih.gov]; Will and Hinzmann, 1995; Kinoh et al., 1996; Apte et al., 1997; Ryu et al., 2001; Wang and Moser, 2008; Otey et al., 2009) . To assess the binding of MT1-MMP to these proteins, we used recombinant glutathione S-transferase (GST) fusions of myotilin and palladin (90-kDa isoform) to pull down MT1-MMP from the lysate of COS1 cells expressing human influenza virus hemagglutinin (HA) epitope-tagged MT1-MMP. MT1-MMP bound to both myotilin and palladin, whereas no binding to GST alone was observed by immunoblotting ( Figure 1B) . To verify the involvement of MT1-MMP C-terminus in palladin binding, we used fulllength and the cytoplasmic tail-deleted mutant of MT1-MMP in the GST pull down. Full-length MT1-MMP bound palladin, whereas no binding of the cytoplasmic tail-deleted mutant was observed by immunoblotting ( Figure 1C ). To further define the palladin domains involved in this interaction, we used GST-tagged palladin fragments (Figure 1 , A and D). MT1-MMP bound most prominently to the C-terminal Ig domains of palladin (Ig3-5; Figure 1 , D and E), whereas the binding with Ig5-C fragment was less efficient (Figure 1, D and E) . The C-termini of MT1-MMP, MT2-MMP, and MT3-MMP are homologous, with 73 and 66% identity of MT1-MMP to MT2-MMP and MT3-MMP, respectively, and >50% identity between all the three sequences. Therefore we tested the binding of these other MT-MMPs to palladin. Similarly to MT1-MMP, MT2-MMP and MT3-MMP bound to GST-palladin ( Figure 1D ).
To verify the interaction of MT-MMP cytoplasmic tail and palladin, we used biotinylated synthetic peptides consisting of the intracellular C-terminal 20 amino acids of MT1-MMP, MT2-MMP, and MT3-MMP, as well as a peptide with scrambled sequence of the 20 amino acids of MT1-MMP. The peptides were incubated with lysate from COS1 cells expressing HA-tagged palladin, and the peptide-protein complexes were pulled down using streptavidin Sepharose. Palladin bound to all the peptides with MT-MMP sequence but not to the scrambled peptide ( Figure 1F ). For the binding to full-length MT1-MMP, the Ig4-5 domains, most homologous to the yeast two-hybrid hit domains of myotilin, were sufficient, as shown by coimmunoprecipitation ( Figure 1G ). Together these results indicate that the C-terminal Ig domains of 90-kDa palladin isoform bind to the intracellular C-terminus of the MT-MMPs.
The 90-kDa isoform of palladin is coexpressed with MT1-MMP in mesenchymally invasive carcinoma cells
To investigate the potential function of the palladin-MT1-MMP interaction in tumor cell invasion, we first analyzed the expression of these proteins in cultured cancer cells (Figure 2, A-D) . In the MDA-MB-231, Hs578T, SUM159, and BT549 invasive human breast cancer cells (TNBC cell lines), different levels of both MT1-MMP and palladin were expressed ( Figure 2A ; Sugiyama et al., 2013) . Palladin was detected as the main protein forms of 90 and 140 kDa in size ( Figure 2A ). The 90-kDa palladin was abolished, and the 140-kDa form reduced by a pool of small interfering RNAs (siRNAs) designed to target the different palladin isoforms (Figure 2 , B and C, and Supplemental Figure S1 , A and B). In contrast, siRNAs targeting the sequence close to the Ig2 domain (absent from 90-kDa isoform) decreased mostly 140-kDa palladin while having minor effects on the 90-kDa form ( Figures 1A and 2 , B and C, and Supplemental Figure S1 , A and B). This indicates that these two palladin proteins are produced by separate transcripts.
(MMP14) is the most widely expressed member of the MT-MMP family and a major cellular collagenase, whose overexpression by tumor cells correlates with the transition of neoplastic epithelial cells to invasive mesenchymal cells (Rowe and Weiss, 2009; Sugiyama et al., 2010a) . MT1-MMP accumulates at tumor cell invasive fronts and invadopodia, which are actin-rich membrane protrusions specialized for ECM degradation in invasive cancer cells (Nakahara et al., 1997; Lehti et al., 2000; Poincloux et al., 2009; Murphy and Courtneidge, 2011) . The recruitment of the cytoskeletal protein cortactin, the nonreceptor tyrosine kinase Src, and MT1-MMP is essential for the maturation of functional invadopodia (Poincloux et al., 2009; Murphy and Courtneidge, 2011) . Although the trafficking of MT1-MMP has been extensively studied, the mechanisms by which the microtubular vesicular trafficking is linked to MT1-MMP localization and function in the actin-based invadopodia or related membrane protrusions remain incompletely understood (Jiang et al., 2001; Uekita et al., 2001; Galvez et al., 2002; Remacle et al., 2003; Mazzone et al., 2004; Wang et al., 2004; Bravo-Cordero et al., 2007; Poincloux et al., 2009 ).
Here we identify, based on an unbiased screen with a genomewide mouse cDNA library, novel interactions between MT1-MMP and the cytoskeletal proteins myotilin and palladin. Palladin, belonging to the myotilin/palladin/myopalladin immunoglobulin (Ig) domain-containing protein family, is expressed ubiquitously as major 90-and 140-kDa isoforms . Palladin functions as a dynamic scaffold protein by binding to actin and actin-associated proteins, such as α-actinin, VASP, and profilin (Boukhelifa et al., 2004 (Boukhelifa et al., , 2006 Ronty et al., 2004; Endlich et al., 2009) . It is a Src substrate involved in the formation of ECM-contacting cytoskeletal structures Ronty et al., 2007; Goicoechea et al., 2009 Goicoechea et al., , 2014 Brentnall, 2012) . High palladin expression in cancer cells or cancer-associated fibroblasts (CAFs) has been associated with increased invasiveness of pancreatic, colorectal, and breast cancers (Ryu et al., 2001; Ronty et al., 2006; Otey et al., 2009; Goicoechea et al., 2009; Brentnall, 2012) . However, antimigratory functions have also been reported, and precise mechanisms of palladin action in cancer progression remain unclear (Chin and Toker, 2010) . Because palladin is a dynamic scaffold protein, with even 30-fold faster turnover than actin or α-actinin in filamentous actin (F-actin)-containing membrane structures, the identified interaction provides cells with a unique mechanism to endorse mesenchymal tumor cell invasion by dynamic coordination between ECM proteolysis and the cytoskeleton (Endlich et al., 2009; Gateva et al., 2014) .
RESULTS

Palladin and myotilin are novel MT-MMP-interacting proteins in vitro
The extracellular domains of MT1-MMP mediate pericellular protein interactions and ECM proteolysis, whereas the transmembrane and cytoplasmic domains regulate MT1-MMP localization and trafficking Jiang et al., 2001; Poincloux et al., 2009; Sugiyama et al., 2010b; Schroder et al., 2013; Mori et al., 2013) . To search for intracellular binding partners that regulate the subcellular localization and proinvasive functions of MT1-MMP, we systematically screened an E17 mouse embryonic cDNA library by yeast twohybrid using C-terminal MT1-MMP cytoplasmic tail (amino acids [aa] 563-582) as a bait. Two of the positive cDNA clones encoded Cterminal Ig domains of the cytoskeletal protein myotilin ( Figure 1A) .
The interaction between MT1-MMP and myotilin, a protein mainly expressed in muscle, can be relevant for myogenesis or myoblast function (Salmikangas et al., 2003; Ohtake et al., 2006) . (Figure 2A ). Both PC3 and DU145 prostate cancer cells also coexpressed MT1-MMP and palladin ( Figure 2D ). Consistent with the coexpression in breast cancer cells, the more mesenchymally invasive PC3 cells expressed 90-kDa palladin, whereas this isoform was negligible in the collectively invasive DU145 cells ( Figure 2D ; Sugiyama et al., 2010a) . Therefore the major palladin isoforms were widely expressed in different cancer cells, but the 90-kDa isoform was mainly coexpressed with MT1-MMP in the mesenchymally invasive cells.
Palladin and MT1-MMP interact in cell-ECM adhesions and invadopodia
To characterize the palladin-MT1-MMP interaction, we first assessed the localization of the endogenous proteins in mesenchymally invasive breast carcinoma cells. As expected, palladin colocalized with its known interaction partners, F-actin and α-actinin, in Hs578T breast carcinoma cells ( Figure 3A ; Ronty et al., 2007; Dixon et al., 2008) . Moreover, palladin colocalized with both phosphorylated focal adhesion kinase (pFAK) and the invadopodia marker cortactin, indicating that palladin specifically localizes to ECM contacting and degrading structures in these invasive breast cancer cells ( Figure 3B ). Of importance, palladin and MT1-MMP were colocalized in actin-rich structures such as focal adhesions (FAs) or membrane ruffles at the cell edge and dot-like invadopodia at the ventral side of Hs578T, MDA-MB-231, and SUM159 cells, as well as in PC3 prostate carcinoma cells ( Figure 3C and Supplemental Figure S1C ). Of interest, in Hs578T cells with strong stress fibers, the colocalization was most prominent at the edges, whereas the other cells displayed predominant colocalization at more central invadopodia-like structures ( Figure 3C and Supplemental Figure S1C ). Consistent with the in vitro interaction results and colocalization, the activated form of MT1-MMP was coprecipitated in the same protein complexes with palladin and coenriched after overexpression of the 90-kDa palladin in Hs578T cells ( Figure 3D ).
Palladin regulates ECM degradation
Previously, palladin was to function in the assembly of actin-based membrane protrusions linked to ECM degradation (Goicoechea et al., 2006 (Goicoechea et al., , 2014 Dixon et al., 2008; Otey et al., 2009; Brentnall, 2012) . However, the physical interaction of palladin and Of note, the mesenchymally invasive Hs578T and SUM159 cells, as well as MDA-MB-231 cells, contained 90-kDa palladin at markedly higher levels than BT549 cells, which express MT1-MMP but display a more rounded morphology during invasion in three-dimensional (3D) collagen, or the MT1-MMP-negative, noninvasive breast carcinoma cells (T47D, BT474, ZR75.1, MCF7, and MDA-MB-453; Figure 2A ; Sugiyama et al., 2013) . The levels of the 140-kDa palladin bound palladin pulled down using streptavidin Sepharose was detected by immunoblotting. (G) The HA-tagged Ig domains 4 and 5 or full-length palladin expressed in COS-1 cells was bound to anti-HA-conjugated agarose beads and allowed to interact with lysates from COS1 cells transfected with control (Mock) or MT1-MMP vectors. Bead-bound proteins were detected by immunoblotting as indicated. GAPDH served as loading control. MT1-MMP precipitates with both Ig domains 4 and 5 and full-length palladin. The detection of 140-and 90-kDa palladin isoforms (arrows) was verified by transfection with scrambled (siCtrl), a pool of siRNAs designed to target the different palladin isoforms (siPalladin), and a specific siRNA targeting the mRNA sequence of the 140-kDa isoform (aa 625-629; UniProt ID Q8WX93), absent from the 90-kDa palladin. (D) Palladin (arrows) and MT1-MMP protein expression in PC3 and DU145 cells. Palladin was detected using an antibody recognizing all the major isoforms and MT1-MMP with an antibody against the catalytic domain recognizing both the latent and active protease. Where indicated, an antibody against the N-terminus of the 140-kDa isoform not present in the 90-kDa palladin (4Ig Ab) was used. α-Tubulin or GAPDH served as loading control (n = 3). MT1-MMP identified here raises the additional possibility of moredirect involvement of palladin in ECM degradation. To assess whether palladin regulates ECM degradation in invadopodia or focal adhesions, we analyzed cell-subjacent gelatin degradation. Hs578T cells displayed matrix degradation at palladin-containing FA-like edge structures and to some extent at more centrally located invadopodia ( Figure 3E ). In MDA-MB-231 cells with less abundant stress fibers and FAs, palladin localized more prominently to the matrix-degrading invadopodia underneath the cells ( Figure 3E ). Significantly, silencing of palladin reduced the number of these ECM degradation spots ( Figure 3F ). This was not associated with dramatic changes in the actin cytoskeleton, although the overall F-actin was slightly decreased in conjunction with reduced accumulation of MT1-MMP at the cell edge structures (Supplemental Figure S1 , D and E).
Palladin-MT1-MMP interaction promotes tumor cell invasion in 3D collagen
To investigate whether palladin regulates MT1-MMP-driven cell invasion, we stably expressed green fluorescent protein (GFP) or GFPpalladin (90 kDa; Figure 4 , A and B) in WM852 melanoma cells, which were essentially devoid of endogenous palladin but expressed MT1-MMP ( Figure 4B ). Whereas all the MT1-MMP-expressing breast cancer cell lines show invasive activities in collagen, the control WM852 cells display an MT1-MMP-dependent expansive growth phenotype with limited collagen invasive ability as single cells or multicellular sprouts (Figure 4, C and D; Tatti et al., 2011; Sugiyama et al. 2013) . To assess the effects of the 90-kDa palladin on cell-invasive growth and dissemination, we implanted control and GFP-palladin-expressing cells as single-cell suspension or preformed spheroids of 500 or 3000 cells in 3D matrix. Cross-linked collagen that typifies tumor adjacent ECM was used as the cell-surrounding matrix, for which MT1-MMP-dependent pericellular proteolysis is required for cell invasion (Rowe and Weiss, 2009; Sugiyama et al., 2010a; Tatti et al., 2011) . During a 7-d culture, the singly embedded control cells grew to form cohesive, noninvasive colonies ( Figure 4C ). Of importance, palladin changed this growth pattern to efficient invasion as single elongated cells with a mesenchymal morphology in 3D collagen ( Figure 4C) . Similarly, the palladin-expressing cells invaded out from the preformed spheroids as single cells with prominent cellular protrusions projecting into collagen ( Figure 4D and Supplemental Figure S2A ). This invasion, as well as the interaction of overexpressed MT1-MMP and palladin, was exacerbated in these cells by platelet-derived growth factor (PDGF)-AB (see Materials and Methods; Figure 4 , E and F, and Supplemental Figure S2A ). Moreover, control cells seeded atop collagen displayed only limited invasive ability even in the presence of the growth factor as a chemoattractant, whereas palladin overexpression specifically increased the number of invasive cells by greater than fivefold (Figure 4, G and H) . Of note, palladin did not alter cell growth or disrupt the overall integrity of the actin cytoskeleton in 2D culture ( Figure 4A and Supplemental Figure S2B ).
To further examine whether the 90-kDa palladin increased cell invasion via MT1-MMP, we silenced endogenous MT1-MMP in the palladin-expressing cells and followed colony growth in 3D collagen (Figure 4, I and J) . Whereas the control siRNA-transfected cells invaded efficiently, MT1-MMP silencing specifically decreased the palladin-induced cell invasion (Figure 4 , I and J). Because both MT1-MMP and palladin are Src substrates and closely associated with Src signaling, which is also critical for invadopodia and FA function, we tested the effect of Src inhibition on the palladin-induced invasion (Nyalendo et al., 2007; Ronty et al., 2007; Ouyang et al., 2010; Sugiyama et al., 2010a) . Of note, PP2, the inhibitor of Src family kinases, similarly prevented invasion, as well as the PDGF-AB-induced tyrosine phosphorylation of GFP-palladin (Figure 3 , K and L). These results indicate that the overexpressed 90-kDa palladin was sufficient to induce mesenchymal-type invasion of the PDGF-AB-stimulated WM852 cells from a cohesive cell mass into surrounding 3D collagen in an MT1-MMP and Src dependent manner.
Palladin is essential for efficient mesenchymal breast carcinoma cell invasion
To examine the function of endogenous palladin in the MT1-MMPdependent collagen invasion, we used Hs578T and MDA-MB-231 cells, where palladin was constitutively tyrosine phosphorylated in a Src-dependent manner (Supplemental Figure S3, A and B) . The cells were embedded as single-cell suspension in 3D collagen after transfection with specific siRNA pools. Of interest, MT1-MMP and palladin colocalized at the tips of invading pseudopods in control Hs578T cells that invade with an elongated, front-rear-polarized, mesenchymal morphology with strong stress fibers ( Figure 5A ; Sugiyama et al., 2013) . In the invading MDA-MB-231 cells, these proteins colocalized at small spot-like structures behind the protruding tips ( Figure 5B ). Of note, the silencing of palladin diminished MT1-MMP localization to the Hs578T pseudopods in conjunction with impaired directional cell movement and extensions, as well as cortactin localization in protrusions in 3D collagen ( Figure 5 , C-E, and Supplemental Figure S3B ).
During a 6-d culture in 3D collagen, Hs578T and MDA-MB-231 control cells grew to form invasive colonies with different types of multicellular outgrowths and singly invading cells ( Figure 6A ). Knockdown of MT1-MMP reduced collagen invasion, as reported previously ( Figure 6 , A-C; Sugiyama et al., 2013) . Significantly, palladin depletion also reduced collagen invasion without markedly altering the levels of cortactin or the EMT markers vimentin, E-cadherin, Ncadherin, and cadherin11 ( Figure 6 , A-C). The 90-kDa palladin remained efficiently depleted during the assay, whereas the 140-kDa isoform was only partially silenced, as assessed by immunoblotting of the cell extracts 3 and 6 d after siRNA transfection (Supplemental Figure S3B ). The growth of the cells in 2D remained unaltered after the knockdown of palladin or MT1-MMP (Supplemental Figure S3C) .
To study the effect of palladin isoforms on cell invasion, we cultured preformed spheroids containing Hs578T or MDA-MB-231 cells, transfected with either total palladin siRNA or siRNA targeting the 140-but not the 90-kDa isoform, in 3D collagen for 3 d ( Figures  2C and 6D ). Palladin depletion reduced significantly the number of invasive sprouts compared with control cells, whereas silencing of the 140-kDa palladin only slightly reduced invasion (Figures 2C and 6, D and E) . Of importance, in the MT1-MMP and 90-kDa palladinnegative MCF7 cells, GFP-palladin expression did not confer invasive abilities or alter the 3D cell phenotype ( Figure 6F ). Together these results indicate that the 90-kDa palladin isoform cooperates with MT1-MMP in cancer cell invasion in collagen.
Palladin Ig4-5 fragment inhibits cell invasion
Because palladin binds MT1-MMP through the Ig domains (Figure 1 , D and G), Ig4-5 domains being sufficient for the binding, we expressed a palladin fragment containing these domains in Hs578T cells. This fragment, which lacks most of the protein binding sites for dynamic scaffold functions, acquired stable localization in strong peripheral membrane clusters, where it partially colocalized with the endogenous palladin ( Figure 7, A and B) . To assess the effects of the Ig4-5 fragment on the functional interaction of endogenous palladin and MT1-MMP in invasion, the cells overexpressing this fragment were seeded atop 3D collagen. During a 6-d culture, Ig4-5 significantly inhibited cell invasion (Figure 7, C and D) . In 3D, this fragment localized throughout the cell and at the pseudopods, where it efficiently replaced the endogenous palladin ( Figure 7E ), suggesting a competitive/dominant-negative effect toward the endogenous palladin/MT1-MMP complexes in cell invasion. 
Palladin and MT1-MMP are codistributed in invasive human breast cancer
To investigate the potential biological relevance of the identified interaction, we analyzed the expression and codistribution of palladin and MT1-MMP in human breast carcinoma tissue biopsies. Given our expression results that showed specific coexpression of palladin and MT1-MMP in the TNBC cell lines, as well as the functional interaction in mesenchymal cell invasion typical in TNBC, tissue sections of 12 human TNBCs characterized by EMT and an unfavorable prognosis were subjected to immunohistochemistry Kessenbrock et al., 2010) . The cells in the stained TNBC tissues lacking the prognostic factors oncogene ErbB-2/human epidermal growth factor receptor 2 (HER-2), estrogen receptor (ER), and progesterone receptor (PR) expressed basal cytokeratin CK5/6 and were thus considered as aggressive, basal-like carcinomas (Cheang et al., 2008) . Variable levels of palladin and MT1-MMP coexpression were detected in the main tumor mass or tumor-invasive fronts in each TNBC tissue (n = 12; Figure 8A and Supplemental Figure S4A ), as well as in the tumor or stromal cells of invasive ductal breast carcinomas analyzed (n = 2; Her−2−/ER+/PR+), whereas HER−2+ tumors displayed stronger codistribution of MT1-MMP and palladin in CAFs (n = 3; Figure 8B and Supplemental Figure S4A ). Of importance, both proteins were expressed at significantly higher levels at the tumor perimeter than the inside tumor masses of each TNBC ( Figure 8C and Supplemental Figure S4B ; palladin, p < 0.01; MT1-MMP, p < 0.05). As such, the coexpression was strongest at tumor-stroma borders in mesenchymal-like TNBC, suggesting that the palladin-MT1-MMP interaction can operate in the invasion of breast carcinoma cells in vivo.
DISCUSSION
To facilitate metastasis and cell invasion through tissue microenvironments, many types of tumor and stromal cells up-regulate MT1-MMP for efficient ECM degradation and remodeling (Seiki, 2003; Rowe and Weiss, 2009) . Although several reports describe MT1-MMP proteolysis at the invadopodia or invasive pseudopods, the mechanisms directing this membrane protease to segments that consist of minimal motifs for binding separated by varying number of amino acids in primary sequence (Jones and Thornton, 1996; Calderwood et al., 2003; Solmaz et al., 2008) . Although the coexpression of MT2-MMP or MT3-MMP prerequisite for the palladin interaction will need to be examined, the 20-amino acid cytoplasmic tails of MT1-MMP, MT2-MMP, and MT3-MMP can share a common palladin-binding motif, as they all bound palladin in vitro.
An exocyst complex coordinates MT1-MMP delivery from the microtubular network to the actin-rich invadopodia, a localization also regulated by cortactin, Tks4, and neural Wiskott-Aldrich the actin-rich core of these invasive structures have remained poorly understood (Poincloux et al., 2009; Murphy and Courtneidge, 2011) . We identified here the Ig domain-containing, actin-associated scaffold protein palladin as a unique linker between the actin cytoskeleton and the pericellular ECM-degrading protease MT1-MMP in invasive cancer cells. This was based on our yeast two-hybrid screen, with the two Ig domains of myotilin identified as the MT1-MMP cytoplasmic tail-interacting hit. Such common interaction properties of myotilin and palladin were anticipated by high overall homology of the palladin and myotilin C-terminal Ig domains. However, protein interaction interfaces can also be composed of short structural breast and prostate carcinoma cells have not been previously defined. Here we found that the carcinoma cell lines contained mainly 90 and 140-kDa palladin. In the mesenchymal breast carcinoma cell lines, the 90-kDa palladin was specifically coexpressed with MT1-MMP, where its efficient knockdown, coupled with only partial reduction of the 140-kDa palladin, inhibited ECM degradation and invasion. Moreover, specific knockdown of the 140-kDa palladin reduced invasion less efficiently. Of importance, ectopic expression of the 90-kDa palladin isoform was sufficient for induction of a dramatic mesenchymaltype cell invasion of MT1-MMP-expressing, but not of MT1-MMP-negative, tumor cells. Therefore our results strongly suggest a unique function for the 90-kDa palladin in the regulation of MT1-MMP-driven ECM degradation and cell invasion.
The 90-kDa palladin contains an N-terminal proline-rich region, followed by the identified C-terminal MT1-MMP-binding Ig domains (Ig3-5). The Ig3-5 domains contain the actin-bundling activity of palladin, the Ig3 domain being sufficient for the actin binding, whereas Ig4-5 domains bind cortical actin-associated ezrin Dixon et al., 2008; Beck et al., 2013) . Several adaptor, actin regulatory, and signaling proteins, such as VASP, profilin, SPIN-90, eps8, and Src, instead interact with palladin through the SH3 domain-binding proline-rich region, establishing palladin as a signaling scaffold important for cytoskeletal dynamics (Boukhelifa et al., 2004 (Boukhelifa et al., , 2006 Goicoechea et al., 2006; Ronty et al., 2007) . Moreover, interactions through the C-terminal PDZ domainbinding motif target palladin to stress fibers (Maeda et al., 2009; von Nandelstadh et al., 2009) . We found that the invasion induced by 90-kDa palladin was sensitive to Src inhibition and associated with Src family kinase-mediated palladin phosphorylation coincident with the palladin-MT1-MMP interaction. Previously, Src was shown to induce relocalization of palladin to Src-and actin-containing membrane extensions in conjunction with actin remodeling in fibroblasts (Ronty et al., 2007) . This is consistent with a key activity of Src in connecting actin cytoskeleton and MT1-MMP through the identified palladin interaction. However, the Src-binding, proline-rich region and the other sites for the foregoing interactions are also included in the 140-kDa palladin, which differs from the 90-kDa isoform by containing an additional N-terminal Ig domain and a second proline-rich region . As such, a potential inhibitory effect of these 140-kDa, isoform-specific domain repeats on the scaffold functions and cross-talk with Src by, for example, conformational means or alternative interactions will be of interest . Consistently, the palladin Ig4-5 fragment, which lacks most of the scaffold sites, accumulated at cell edges similarly to what was reported for 140-kDa palladin. Moreover, the Ig4-5 fragment localized to the tips of invasive pseudopods, where it efficiently replaced endogenous palladin. The observed dominant-negative effect of this Ig4-5 fragment on collagen invasion further emphasizes the importance of palladin in the MT1-MMP-dependent cell invasion. syndrome protein (Buschman et al., 2009; Poincloux et al., 2009; Yu et al., 2012) . However, direct binding of these proteins to MT1-MMP has not been described (Buschman et al., 2009; Poincloux et al., 2009; Yu et al., 2012) . Based on precipitation with isolated rabbit muscle actin, direct F-actin-mediated capture of MT1-MMP has instead been suggested to stably target MT1-MMP to invasive pseudopods (Yu et al., 2012) . In contrast to the relatively stable Factin assembly in invasive structures, dynamic MT1-MMP turnover is considered essential for efficient or sustained proteolysis within inhibitor-rich tissue microenvironments (Artym et al., 2006; Watanabe et al., 2013) . Because palladin is a cancer-associated scaffolding protein with considerably faster turnover than actin or α-actinin in membrane ruffles and FAs, the interaction identified here provides cells with a more dynamic mechanism for invadopodial MT1-MMP targeting (Endlich et al., 2009; Gateva et al., 2014) .
Palladin is ubiquitously expressed in several isoforms of three to five Ig domains flanked by one or two proline-rich regions ( Figure 1A ; Rachlin and Otey, 2006; Ronty et al., 2006; Wang and Moser, 2008; Goicoechea et al., 2010) . Whereas differential expression and actinorganizing properties of the isoforms have been reported, their specific functions have remained unclear in diverse cell types Goicoechea et al., 2009; Otey et al., 2009 ). In cancer, the overall palladin expression has been mainly linked to increased invasion, but antimigratory or antitumorigenic functions have also been reported, which could be related to the expression of different isoforms in specific cancers Otey et al., 2009; Goicoechea et al., 2009; Chin and Toker, 2010; Tay et al., 2010; Asano et al., 2011; Brentnall, 2012) . The isoforms expressed in CAFs, we conceive that the palladin-MT1-MMP interaction identified here likely affects the invasion and function of different cell types with the actin-based contractile cytoskeleton, such as mesenchymal cancer cells, CAFs, or myofibroblasts and smooth muscle cells.
MATERIALS AND METHODS
Yeast two-hybrid screening
The MT1-MMP cytoplasmic tail encoding amino acids 563-582 was used to screen a mouse 17-d embryo matchmaker cDNA library in pACT2 (ML4013AH; Clontech Laboratories, Palo Alto, CA), essentially as described (Gyuris et al., 1993) . Positive clones were subjected to sequence analysis or analyzed by digestion.
Taken together, the present results identify a unique palladin-MT1-MMP interaction that helps to explain 1) palladin function in mesenchymal cancer cell invasion and 2) the dynamic targeting and turnover of MT1-MMP in invasive pseudopods. In addition to the proinvasive MT1-MMP function on tumor cells, substantial evidence supports a critical role of this protease in the invasive and tissue-remodeling functions of mesenchymal stromal cells such as CAFs. Palladin expression has also been associated with myofibroblast phenotype and CAF invasion Brentnall, 2012; Goicoechea et al., 2014) . We found extensive MT1-MMP and palladin coexpression in both spindle-shaped tumor cells, in which cancer-related EMT likely occurs, and tumor-adjacent CAFs. Because the mesenchymal invasion of cancer cells recapitulates the invasive activities of FIGURE 8: (A, B) Palladin and MT1-MMP immunohistochemistry of tissue biopsies from basal-like triple-negative (A) and other human breast cancer subtypes (B). Palladin expression was visualized using an antibody recognizing the major, 90-, 140-, and 200-kDa, isoforms and MT1-MMP using an antibody against the catalytic domain recognizing both the latent and active protease. Palladin and MT1-MMP colocalize in the invasive carcinoma cells and reactive stroma. Bottom, magnifications of the framed areas (n = 17; see also Supplemental Figure S4 , including control staining). (C) Quantitative image analysis of palladin and MT1-MMP staining in two fields per specimen quantified by Anduril (http://csbi.ltdk.helsinki.fi/anduril/site/). The mean densities at the interior and perimeter were compared using the paired two-tailed Student's t test. The p values were corrected with the Bonferroni correction. Error bars indicate SD. Palladin and MT1-MMP were expressed at significantly higher levels at the tumor perimeter than inside of the tumor masses (see also Supplemental Figure S4 ). QLSLPLDLKYRTGVHRR (scrambled; JPT Peptide Technologies, GmbH, Berlin, Germany).
Cell transfections and treatments
The cells were transfected with expression vectors using FuGENE HD (Promega, Madison, WI). siRNAs (siGENOME SMARTpool; Dharmacon, Thermo Scientific, Waltham, MA) against human PALLD (M-016891-01-0005) and MMP14 (MT1-MMP; M-004145-00-0005) and nontargeting control siRNA, as well as a siRNA duplex targeting the mRNA sequence in the corresponding transcripts encoding 200-and 140-kDa palladin isoforms (aa 625-629; isoform1-200 kDa; UniProt ID Q8WX93), absent from the 90-kDa palladin isoform CDS (GGCAAAGCUAACAGUAAUAdTdT, dTdTCCGUUUCGAUUGUCA-UUAU; Dharmacon, Thermo Scientific; Rachlin et al., 2006) were transfected using Lipofectamine 2000 (Invitrogen) . Western blotting after 72 or/and 96 h monitored knockdown efficiency. For immunofluorescence, cells were seeded on monomeric collagencoated (100 μg/ml) coverslips, fixed, and stained as previously described (von Nandelstadh et al., 2005) and mounted in Vectashield with 4′,6-diamidino-2-phenylindole (DAPI; Vector Laboratories, Burlingame, CA). Fluorescence images were obtained using an LSM 5 DUO confocal microscope with a Plan-Apochromat 40×/1.3 numerical aperture (NA) oil objective and with Plan-Apochromat 10×/0.45 NA objective or using an LSM 780 confocal microscope with Plan-Neofluar 40×, 1.3 NA oil objective. In addition, an AxioImager.Z1 upright epifluorescence microscope with Apotome and Plan-Apochromat 40×/1.4 NA oil objective and an Axioplan 2 upright epifluorescence microscope were used (all from Carl Zeiss, Oberkochen, Germany). Brightness and contrast were linearly adjusted using Photoshop CS5.1 (Adobe, San Jose, CA). Single optical sections or a combination of two serial optical sections were used for image display.
In vitro binding assays
GST, GST-myotilin, GST-palladin, and GST-palladin fragments were produced as described . COS1 cells were transfected to express HA-tagged MT1-, MT2-, or MT3-MMP and lysed with 140 mM NaCl, 1 mM Tris, pH 7.5, 1% Triton X-100, 10 μM GM6001, and Complete protease inhibitors (Roche, Indianapolis, IN). Cleared supernatants were incubated with GST fusion proteins bound to glutathione-Sepharose overnight at 4°C. Alternatively, cleared lysates from COS1 cells expressing HAtagged palladin were allowed to interact with synthesized biotinylated peptides representing the intracellular C-terminal 20 amino acids of MT1-MMP, MT2-MMP, and MT3-MMP as well as a scrambled peptide for 2 h at 4°C. The peptide-protein complexes were pulled down by rotation with Streptavidin Sepharose Bead Conjugate (Cell Signaling Technology) overnight at 4°C. After washing, the bound proteins were detected by SDS-PAGE and immunoblotting. Band intensities were quantified using ImageJ software (National Institutes of Health, Bethesda, MD). immunoprecipitated from soluble lysates by specific rabbit polyclonal antibodies and GammaBind G Sepharose (GE Healthcare). Alternatively, HA-tagged proteins were immunoprecipitated with anti-HA-agarose beads (Sigma-Aldrich). See Supplemental Materials and Methods for immunoprecipitation from COS1 cells, real-time qPCR, cell proliferation assay, and gelatin zymography.
Three-dimensional type I collagen growth and invasion assays Type I collagen (2.2 mg/ml) was prepared; invasion and growth were assessed essentially as described (Sugiyama et al., 2013) . For invasive growth assay, a single-cell suspension (3 × 10 3 cells/ml) or spheroids of 500 or 3000 cells preformed under nonadherent conditions were mixed in collagen and cultured for 5 d. Based on initial growth factor testing (epidermal growth factor, hepatocyte growth factor, fibroblast growth factor, PDGF-AA, PDGF-AB, PDGF-BB), PDGF-AB (20 ng/ml) was used to stimulate WM852 cell invasion. Cultures were fixed and immunostained. The number of sprouts per colony or number of invading colonies was manually counted. Relative colony size (area) and length of sprouts were quantified using ImageJ software from random epifluorescence or phase contrast images of three to six gels.
PDGF was used as a chemoattractant (WM852 cells) in the invasion assay. After 5 (Hs578T) or 15 d (WM852), cells were fixed, and paraffin sections were stained with hematoxylin and eosin (H&E staining). Sections were photographed (Leica DM LB; Leica Microsystems, Wetzlar, Germany; or Zeiss AxioImager.Z1 epifluorescence microscope), and the cells that invaded >10 μM (WM852) or total number of invading cells (Hs578T) were counted from at least three random sections of each sample.
Immunohistochemistry
Breast carcinoma tissue biopsies were collected, fixed, and immunohistochemically stained as described (Gardberg et al., 2010) . As specificity controls, the sections were also stained with mouse and rabbit preimmune serum. Each specimen was used with the approval of the Hospital District of Southwest Finland Ethics Committee.
Quantitative image analyses
To score the stainings, palladin and MT1-MMP positivity was evaluated from two random microscopic fields of each TNBC with the Leica DM LB bright-field microscope with an N Plan 20×/0.4 NA objective. Quantitative image analyses were performed using Anduril (Ovaska et al., 2010) . The colors of each image were categorized into four expected representative color classes: brown, light brown, blue, and white. Only the brown and light brown classes were considered for staining density measurement. The color classes were selected by pointing at seven example colors for each class. The MT1-MMP and palladin staining colors were selected separately. All of the 24 images within the same staining were subjugated to use the same class specification. The regions of interest (ROIs), tumor interiors, and perimeters were drawn on the images. The density within each ROI was measured only in the brown and light brown color classes. The mean densities at the interior and perimeter were compared using the paired two-sided Student's t test. The p values were corrected with the Bonferroni correction.
Statistical analysis
All numerical values represent mean ± SD or SEM. Statistical significance was determined using the Mann-Whitney or Student's t test.
